# Diarrhea Predominant Irritable Bowel Syndrome in Females

> **NCT00461526** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 240 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** crofelemer

## Key facts

- **NCT ID:** NCT00461526
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461526, "Diarrhea Predominant Irritable Bowel Syndrome in Females". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00461526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*